Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic …

Rigel is the brightest and most massive component – and the eponym – of a star system of at least four stars that appear as a single blue-white point of light to the naked eye. This system …

Rigel Medical provides trusted test solutions and training to Biomedical Engineers worldwide, ensuring medical equipment safety for over 30 years.

Jan 5, 2026 · Rigel Pharmaceuticals has seen its fair value estimate nudged up from US$49.60 to US$51.20, with only a small adjustment to the discount rate from 7.12% to 7.14% and revenue …

Jan 1, 2026 · Rigel Pharmaceuticals (RIGL) Q3 2025 beats and raised guidance. Learn more on key growth drivers, 2026 transition risks, and what to monitor.

Get real-time Rigel Pharmaceuticals (RIGL) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

4 days ago · Rigel reported strong 2025 growth, with revenue and cash rising sharply. Clinical and regulatory advances bolster Rigel’s hematology-oncology portfolio and 2026 outlook. Looking …

Rigel, one of the brightest stars in the sky, intrinsically as well as in appearance. A blue-white supergiant in the constellation Orion, Rigel is about 860 light-years from the Sun and is about …

4 days ago · "2025 was an excellent year for Rigel, marked by strong commercial execution with record net product sales; significant financial progress, including continued profitability and …

4 days ago · Rigel plans to release preliminary results from the dose expansion phase of the R289 study and explore opportunities to enhance its product portfolio. Rigel Pharmaceuticals …